BLOG

CAR-T Therapy Development on the Rise

Now, the biotech company Celyad is looking for a non-gene-edited approach to create allogeneic CAR-T cells using RNAi. Last October, Celyad announced a collaboration with shRNA experts Dharmacon, a Horizon Discovery company, to use their optimized shRNA technology to create CAR-T therapies.

Back to the Blog .st0{stroke:#000;stroke-width:3}.st0,.st1{fill:none}